-+ 0.00%
-+ 0.00%
-+ 0.00%

Aytu BioPharma Q2 EPS $(0.28), Inline, Sales $16.22M Beat $15.55M Estimate

Benzinga·02/12/2025 21:14:47
Listen to the news
Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.28) per share which met the analyst consensus estimate. This is a 600 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $16.22 million which beat the analyst consensus estimate of $15.55 million by 4.29 percent. This is a 29.27 percent decrease over sales of $22.93 million the same period last year.